|
Market Closed -
NYSE
16:00:02 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 22.11 USD | +0.64% |
|
-3.11% | +24.21% |
| 10-19 | HC Wainwright Adjusts Alto Neuroscience Price Target to $60 From $55, Maintains Buy Rating | MT |
| 10-02 | Alto Neuroscience Insider Sold Shares Worth $3,567,247, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ANRO | Delayed | |
CBOE
| ANRO | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 26.49 | 36.64 | 35.55 |
| Spread/Res. | -16.53% | -39.66% | -37.81% |
| Spread/Supp. | +1.84% | +21.22% | +64.63% |
| Support | 21.71 | 18.24 | 13.43 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ANRO Stock
- Charts Alto Neuroscience, Inc.
Select your edition
All financial news and data tailored to specific country editions
